Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
anticoagulant/blæðing
Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 95 niðurstöður
Hemorrhagic-lesion producing and anticoagulant-containing compositions and their use
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
Rats, e.g., have particularly good memories and a relatively high intelligence quotient. They are able to connect the toxic effect of rapidly-acting poisons with the type and position of employed bait, and they warn other rats.
Rodenticides comprising anti-coagulating or
Preparation of low bleeding anticoagulant fusion protein and its use
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
This application is a 371 of PCT/CN07/03526, filed Dec. 11, 2007, which claims priority to Chinese patent application 200610165756.7, filed Dec. 16, 2006.
FIELD OF INVENTION
This invention belongs to the area of biotechnology, and relates to structure and preparation of a kind of anticoagulant
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular, the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent hemostasis of the radial artery by compressing the un-instrumented ulnar artery to
Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The entire content of all above applications is incorporated herein by reference.
BACKGROUND OF INVENTION
a. Field of Invention
The invention relates generally to transradial catheterization methods and devices used in said methods. In particular the invention concerns a method of obtaining patent
Modified serpins for the treatment of bleeding disorders
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING
The instant application contains a Sequence Listing (.txt file named Sequence_Listing, having a date of May 4, 2018 and 63,944 bytes in size) which has been submitted in ASCII format via EFS-Web and is incorporated by reference herein.
FIELD
This invention relates to modified serpin
Modified serpins for the treatment of bleeding disorders
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD
This invention relates to modified serpin molecules with altered specificity, in particular serpin molecules modified to have increased specificity for anticoagulant proteases, such as activated Protein C (APC).
BACKGROUND
Hemophilias are bleeding disorders, which are caused by a deficiency in
Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/IB2008/000945, filed on Apr. 18, 2008, which claims the benefit of U.S. Provisional Application No. 60/907,875, filed on Apr. 20, 2007, the entire contents of which are herein
Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect
Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The invention relates to treatment and prevention of a certain form of shock, hypovolemic shock and related syndromes with substantially non-anticoagulant chemically modified heparinoids. The heparinoids preserve the function of heart, liver, kidney and gut, protect
Methods for treating bleeding disorders using sulfated polysaccharides
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)
Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum
- Virkar á 55 tungumálum
- Jurtalækningar studdir af vísindum
- Jurtaviðurkenning eftir ímynd
- Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
- Lestu vísindarit sem tengjast leit þinni
- Leitaðu að lækningajurtum eftir áhrifum þeirra
- Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum
Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum
